<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02434315</url>
  </required_header>
  <id_info>
    <org_study_id>ADC-UK-PMS-14024</org_study_id>
    <nct_id>NCT02434315</nct_id>
  </id_info>
  <brief_title>FreeStyle Libre Pro Use in Primary &amp; Secondary Care</brief_title>
  <official_title>Evaluation of the FreeStyle Libre Pro for Individuals With Insulin Managed Type 2 Diabetes in Primary &amp; Secondary Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Diabetes Care</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Diabetes Care</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the impact of varying amount of FreeStyle Libre Pro&#xD;
      wear as measured by time in range.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline - time in glucose range - for penultimate sensor wear</measure>
    <time_frame>14 day baseline phase compared to day 172 to 187</time_frame>
    <description>Within arm difference in time in range in penultimate period of sensor wear compared to baseline phase</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">175</enrollment>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Group A - Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>FreeStyle Libre Pro 3 sensor wears</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B - Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>FreeStyle Libre Pro 4 sensor wears, 2 with reviews</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C - Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>FreeStyle Libre Pro 6 sensor wears, 4 with reviews</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FreeStyle Libre Pro 4 sensor wears, 2 with reviews</intervention_name>
    <description>Subjects will wear the FreeStyle Libre Pro System for 14 days. 2 period of FreeStyle Libre Pro Sensor wear for data review followed by 2 further periods of Sensor wear for time in range measurement with 28 day interval between wears.</description>
    <arm_group_label>Group B - Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FreeStyle Libre Pro 6 sensor wears, 4 with reviews</intervention_name>
    <description>Subjects will wear the FreeStyle Libre Pro System for 14 days. 4 period of FreeStyle Libre Pro Sensor wear for data review followed by 2 further periods of Sensor wear for time in range measurement with 28 day interval between wears.</description>
    <arm_group_label>Group C - Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FreeStyle Libre Pro 3 sensor wears</intervention_name>
    <description>Subjects will wear the FreeStyle Libre Pro System for 14 days. 3 periods of Sensor wear for time in range measurement over a period of approximately 8 months.</description>
    <arm_group_label>Group A - Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age at least 18 years.&#xD;
&#xD;
          -  Type 2 diabetes treated with insulin therapy for at least 6 months prior to study&#xD;
             enrolment.&#xD;
&#xD;
          -  HbA1c between 58 and 108 mmol/mol (7.5 and 12.0%) inclusive.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age at least 18 years.&#xD;
&#xD;
          -  Type 2 diabetes treated with insulin therapy for at least 6 months prior to study&#xD;
             enrolment.&#xD;
&#xD;
          -  HbA1c between 58 and 108 mmol/mol (7.5 and 12.0%) inclusive.&#xD;
&#xD;
          -  Participant is currently prescribed animal insulin.&#xD;
&#xD;
          -  Total daily dose of insulin (TDD) is &gt;1.75 iu/kg at entry to the study.&#xD;
&#xD;
          -  Concomitant disease or condition that may compromise patient safety including and not&#xD;
             limited to; cystic fibrosis, severe mental illness, a diagnosed or suspected eating&#xD;
             disorder or any uncontrolled long term medical condition.&#xD;
&#xD;
          -  Has a pacemaker or any other neurostimulators.&#xD;
&#xD;
          -  Currently prescribed oral, intramuscular or intravenous steroid therapy for any acute&#xD;
             or chronic condition or requires it during the study period.&#xD;
&#xD;
          -  Currently receiving dialysis treatment or planning to receive dialysis during the&#xD;
             study.&#xD;
&#xD;
          -  Women who are pregnant, plan to become pregnant or become pregnant during the study.&#xD;
&#xD;
          -  Participating in another study of a glucose monitoring device or drug that could&#xD;
             affect glucose measurements or management.&#xD;
&#xD;
          -  Currently using / has previously used a sensor based Glucose Monitoring System&#xD;
             (including retrospective glucose monitoring system) within the last 6 months.&#xD;
&#xD;
          -  Currently using Continuous Subcutaneous Insulin Infusion (CSII).&#xD;
&#xD;
          -  Known (or suspected) allergy to medical grade adhesives.&#xD;
&#xD;
          -  In the investigator's opinion the participant is unsuitable to participate due to any&#xD;
             other cause/reason.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Atherstone Surgery</name>
      <address>
        <city>Atherstone</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Westongrove Partnership</name>
      <address>
        <city>Aylesbury</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pebsham Surgery</name>
      <address>
        <city>Bexhill</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Omnia Practice</name>
      <address>
        <city>Birmingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hathaway Surgery</name>
      <address>
        <city>Chippenham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rowden Surgery</name>
      <address>
        <city>Chippenham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pound Hill Medical Group</name>
      <address>
        <city>Crawley</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Claremont Medical Practice</name>
      <address>
        <city>Exmouth</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>White Horse Medical Practice</name>
      <address>
        <city>Faringdon</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Parkwood Surgery</name>
      <address>
        <city>Hemel Hempstead</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St James Hospital,</name>
      <address>
        <city>Leeds</city>
        <zip>LS9 7TF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kings College Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>James Cook Hospital</name>
      <address>
        <city>Middlesborough</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Milton Keynes Hospital</name>
      <address>
        <city>Milton Keynes</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Greenwood and Sneinton Centre</name>
      <address>
        <city>Nottingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mortimer Surgery</name>
      <address>
        <city>Reading</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clifton Medical Centre</name>
      <address>
        <city>Rotherham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Salford Royal Hospital</name>
      <address>
        <city>Salford</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ashfields Primary Care Centre</name>
      <address>
        <city>Sandbach</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Kiltearn Medical Centre</name>
      <address>
        <city>Sandbach</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Albany House Surgery</name>
      <address>
        <city>Wellingborough</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rothwell Surgery</name>
      <address>
        <city>Wellingborough</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Friarsgate Practice</name>
      <address>
        <city>Winchester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <study_first_submitted>April 27, 2015</study_first_submitted>
  <study_first_submitted_qc>April 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 5, 2015</study_first_posted>
  <last_update_submitted>September 28, 2016</last_update_submitted>
  <last_update_submitted_qc>September 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetes Mellitus</keyword>
  <keyword>Sensing Technology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

